Spain· ES:1251943002
ALYFTREK 125 MG/50 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
A deutivacaftor, tezacaftor, vanzacaftor product containing deutivacaftor, tezacaftor, vanzacaftor, registered in Spain by Vertex Pharmaceuticals (Ireland) Limited.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- deutivacaftor, tezacaftor, vanzacaftor
- Manufacturer
- Vertex Pharmaceuticals (Ireland) Limited
- Country
- Spain (ES)
- ATC code
- Deutivacaftor, Tezacaftor, Vanzacaftor
- ATC class
- Deutivacaftor, Tezacaftor, Vanzacaftor
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under Deutivacaftor, Tezacaftor, Vanzacaftor
Deutivacaftor, tezacaftor, vanzacaftor, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/019d0aac-a701-4d46-937f-d00c152c8070 GET /v1/drugs/019d0aac-a701-4d46-937f-d00c152c8070?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1755077051000}",
"nregistro": "1251943002",
"substance": "deutivacaftor, tezacaftor, vanzacaftor"
}See everything about deutivacaftor, tezacaftor, vanzacaftor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.